Skip to main navigation Skip to search Skip to main content

Copper sulfide: An emerging adaptable nanoplatform in cancer theranostics

  • Kishwor Poudel
  • , Milan Gautam
  • , Sung Giu Jin
  • , Han Gon Choi
  • , Chul Soon Yong
  • , Jong Oh Kim
  • Yeungnam University
  • Hanyang University

Research output: Contribution to journalReview articlepeer-review

74 Scopus citations

Abstract

Copper sulfide nanoparticles (CuS NPs), emerging nanoplatforms with dual diagnostic and therapeutic applications, are being actively investigated in this era of “war on cancer” owing to their versatility and adaptability. This article discusses the pros and cons of using CuS NPs in diagnostics, therapeutics, and theranostics. The first section introduces CuS NPs and discusses the features that render them more advantageous than other established nanoplatforms in cancer management. Subsequent sections include specific in vitro and in vivo results of different studies showing the potential of CuS NPs as nanoplatforms. Methods used for visualization (photoacoustic imaging and magnetic resonance imaging) of CuS NPs and treatment (phototherapy and combinatorial therapy) have also been discussed. Furthermore, the challenges and opportunities associated with using CuS NPs have been elucidated. Further investigations on CuS NPs are required to translate it for clinical applications.

Original languageEnglish
Pages (from-to)135-150
Number of pages16
JournalInternational Journal of Pharmaceutics
Volume562
DOIs
StatePublished - 1 May 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Copper sulfide
  • Nanoplatforms
  • Theranostics
  • Therapeutics

Fingerprint

Dive into the research topics of 'Copper sulfide: An emerging adaptable nanoplatform in cancer theranostics'. Together they form a unique fingerprint.

Cite this